Showing 1 - 10 of 118
A new survey finds that only 17 drugs are under active development for maternal health indications, which is less than 3% of the pipeline in cardiovascular health (660 drugs). The international agencies have forgotten pregnant women. Given the unacceptably high number of maternal and perinatal...
Persistent link: https://www.econbiz.de/10005341686
The report discusses the problems posed by one of the most archaic forensic procedures still in use: the finger test. [CEHAT].
Persistent link: https://www.econbiz.de/10008642454
The overarching goals should be to increase the quality of life and years of healthy life for all Americans and to eliminate racial and ethnic health disparities. This has been an ambitious undertaking, but there has been considerable progress. . African Americans and other racial and ethnic...
Persistent link: https://www.econbiz.de/10005487603
The June issue of World Rivers Review is overflowing with ideas on on how to maintain healthy flows in rivers, for their health and our own. If a river's flow is its heartbeat, then we humans have become the heart disease of the world's rivers. The articles in this issue look at three ways to...
Persistent link: https://www.econbiz.de/10009319312
Drug Policy of 1986
Persistent link: https://www.econbiz.de/10009323735
The Drug Policy, 1994 needed to be revised to  meet  the  challenges  brought  about  by  the  competitive  international  pharmaceutical  industry  in  a  globalised  economic  environment,  as...
Persistent link: https://www.econbiz.de/10009358535
Modifications to Drug Policy 1986
Persistent link: https://www.econbiz.de/10009250151
Pharmaceutical Policy of 2002 covering issues of pricing, ,marketing, size of market, quality, production, investment, regulatory authority, monitoring, ethical issues
Persistent link: https://www.econbiz.de/10009250530
This paper reports findings from the survey of India’s textiles and clothing exporters. The survey method has been used to identify and assess the impact of Non-Tariff Measures (NTMs) and the Cost of Compliance (COC) expenditure by the exporters. A structured questionnaire has been used...
Persistent link: https://www.econbiz.de/10008543107
The focus of this paper is India. In line with TRIPS India has introduced a product patent regime in pharmaceuticals …
Persistent link: https://www.econbiz.de/10004988399